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Cystic changes in the white matter can be caused by heterogeneous neurologic 
disorders. They are classified in two main categories: a) cystic finding in association 
with known classic leukodystrophy and b) white matter cystic abnormalities that 
are not seen in the background of a classic leukodystrophy.
The main disorders in group (a) are including: Megalencephalic leukoencephalopathy 
with subcortical cyst(MLC) or vanderknaap disease, RNAase T2 deficiency, 
congenital CMV infection, cerebroretinal microangiopathy with calcificationand 
cysts (coat’s plus syndrome or CRMCC) and less commonly Aicardi-Goutieres 
syndrome and Alexander’s disease. 
 Group (b) consists of various disorders.  Autistic spectrum disorders, 
mucopolysaccharidosis, structural chromosomal abnormalities, migraine headache, 
mitochondrial leukoencephalopathy (complex I, complex II and complex IV 
deficiency) and COL4A1 associated disorder are main diseases that can be classified 
in this group. For some of these disorders, such asautistic spectrum disorders and 
mucopolysaccharidosisCystic changes are thought to be due to dilated Virchow-
robin or perivascular spaces. It is not cleared that cystic findings of white matter in 
these disorders are functional effects or are specific for diagnosis.
Megalencephalicleukoencephalopathy with subcortical cyst (MLC) or van der 
Knaap’s disease is characterized by a mild course and macrocephaly that is a 
cardinal feature for diagnosis and differentiates MLC from RNAase T2 deficient 
leukoencephalopathy, AGS and CMV infection. In the initial stages of disease, 
Patients show mild motor and cognitive delay. Later in life spastic ataxia, epilepsy, 
dysarthric speech and cognitive deterioration are seen. Important brain MRI features 
are including: diffuse white matter signal abnormality with relative sparing of 
central structures and cystic changes in temporal or frontoparietal regions. Genetic 
study and searching for MLC1 gene mutation confirms the diagnosis of MLC.
RNAase T2 deficient leukoencephalopathy that was described for the first time by 
henneke in 2009 is characterized by psychomotor delay, spasticity and epilepsy. Its 
radiologic findings in brain MRI resemble congenital CMV infection and MLC, 
but in contrast to MLC the patient has normo- or microcephaly in association 
with intracranial calcifications. In another hand there is no evidence of CMV 
infection. It must to be mentioned that human RNAase T2 is a catalytic enzyme 
with some new known function about tumor suppression. Its role in this type of 
leukoencephalopathy is still unclear.
Cerebroretinal microangiopathy with calcification and cysts (CRMCC)or 
labrunedisease is an obliterativevasculopathy with unidentified genetic etiology that 
involves multiple organs mainly brain, eyes, liver, intestine and bones. Therefore 
progressive neurologic symptoms, bone fracture and osteopenia, bilateral retinal 
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telangectasia and portal hypertension are main clinical 
symptoms in this disease, although not all organs are 
involved in each patient. Neuroimaging findings are 
a distinct pattern of calcification in white matter of 
brain and cerebellum, basal ganglia and thalamus with 
parenchymal cysts and leukoencephalopathy.
Aicardi-Goutieres syndrome (AGS) is a calcifying 
leukoencephalopathy that can present in both neonatal 
period or in older infants. Symptoms in neonatal period 
resemble a TORCH-like disorder such as congenital 
CMV, but in older infants the disease is characterized 
by progressive microcephaly, dystonia, seizures and 
progressive cerebral atrophy and calcification. One of 
important diagnostic criteria in AGS is CSF findings of 
leukocytes, pterins and interferon-alpha.
Naidu described in 2005 a specific type of cystic 
leukoencephalopathy as named progressive 
cavitatingleukoencephalopathy, but it seems there is 
no consensus on this term and many things can cause 
cavitating degeneration of white matter. For example in 
recent years it has been found that some mitochondrial 
diseases such as complex I deficiency can present with 
progressive cavitating leukoencephalopathy.
Some infectious agents such as CMV, HIV, 
and papoavirus that cause progressive cystic 
leukoencephalopathyare mentioned as a group of 
etiologic factors in association with cystic changes in 
white matter in the literature. 
Therefore, as mentioned before this, cystic 
leukoencephalopathy can be caused by heterogeneous 
factors that may be heritable or acquired.
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